ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join us for the ACC Rockies Chapter Meeting from September 8-9, 2023 at the Hyatt Centric in Park City, Utah. For more information and to register, please visit: https://web.cvent.com/event/314c67f2-d26f-4ad9-bfd7-8011b1bd9dcb/summary
Latest in Cardiology from ACC.org
- Class I Recalls of Cardiovascular DevicesWhat are Class I Food and Drug Administration (FDA) recalls of cardiovascular devices and what is the clinical evidence supporting authorization?
- Recurrent Rejection in Pediatric Heart TransplantationWhat is the prevalence and impact of recurrent rejection (RR) on cardiac allograft vasculopathy (CAV) and graft loss after pediatric heart transplant?
- Early Treatment of Atrial Fibrillation for Stroke Prevention TrialThe goal of the EAST-AFNET 4 trial was to compare a rhythm-control strategy vs. usual care (rate control in the majority of cases) among patients with a recent diagnosis of atrial fibrillation (AF).
- Assessment of Primary Prevention Patients Receiving an ICD–Systematic Evaluation of ATPThe goal of the APPRAISE ATP trial was to determine the efficacy of antitachycardia pacing (ATP) in terminating ventricular tachycardia (VT) compared with a shock-only strategy in patients with a primary prevention implantable cardioverter-defibrillator (ICD).
- ACC CardiaCast: 2024 Update to the AHA/ACC HCM Guideline: Focus on Early Diagnosis and New and Emerging TreatmentsIn this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and review the latest clinical and real-world trial data for new (mavacamten) and emerging (aficamten) cardiac myosin inhibitors.